|
FMNL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60440011171193E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.07779995828628E-09 |
| Normal-vs-Stage2 |
5.77840000000052E-05 |
| Normal-vs-Stage3 |
1.034760E-04 |
| Normal-vs-Stage4 |
3.242700E-04 |
| Stage1-vs-Stage2 |
5.150400E-01 |
| Stage1-vs-Stage3 |
5.464200E-01 |
| Stage1-vs-Stage4 |
8.795600E-01 |
| Stage2-vs-Stage3 |
3.503000E-01 |
| Stage2-vs-Stage4 |
5.458800E-01 |
| Stage3-vs-Stage4 |
7.629000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82280002203328E-09 |
| Normal-vs-AfricanAmerican |
2.116800E-03 |
| Normal-vs-Asian |
3.151900E-02 |
| Caucasian-vs-AfricanAmerican |
8.299800E-01 |
| Caucasian-vs-Asian |
7.582400E-02 |
| AfricanAmerican-vs-Asian |
7.454500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.28739999993854E-07 |
| Normal-vs-Female |
4.62329952100049E-10 |
| Male-vs-Female |
2.737800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.168600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.03780003982246E-09 |
| Normal-vs-Age(61-80Yrs) |
1.87110000049451E-07 |
| Normal-vs-Age(81-100Yrs) |
2.997600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.168800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.701400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.105200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.469600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.944000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.403200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.167200E-04 |
| Normal-vs-Grade 2 |
5.33989996664985E-09 |
| Normal-vs-Grade 3 |
9.29659999981958E-07 |
| Normal-vs-Grade 4 |
3.167000E-04 |
| Grade 1-vs-Grade 2 |
8.835800E-01 |
| Grade 1-vs-Grade 3 |
5.084600E-01 |
| Grade 1-vs-Grade 4 |
8.259600E-01 |
| Grade 2-vs-Grade 3 |
1.930790E-01 |
| Grade 2-vs-Grade 4 |
5.911600E-01 |
| Grade 3-vs-Grade 4 |
2.245200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.05690001195313E-09 |
| Normal-vs-ccB subtype |
2.92710000016072E-07 |
| ccA subtype-vs-ccB subtype |
8.821200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45830003628333E-09 |
| Normal-vs-N1 |
2.671700E-02 |
| N0-vs-N1 |
4.059000E-01 |
|
|
